Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

core/heading

Blank Rome partner <a href="/people/merle-m-delancey/" id="19208">Merle M. DeLancey, Jr.</a> will serve as a presenter for <a href="https://www.americanconference.com/drug-pricing/">Rx Drug Pricing &amp; Rebate Fundamentals</a>, an American Conference Institute (“ACI”) Virtual Proficiency Series program being held November 4 through December 4, 2024.

core/paragraph

ACI’s Rx Drug Pricing &amp; Rebate Fundamentals is an intensive training program that will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

The program is designed to make attendees proficient in essential pricing and rebate concepts under Medicaid, Medicare, and other related government payor programs, including those under the auspices of PHS 340B, the Department of Veterans Affairs (“VA”), and the Department of Defense (“DoD”). The course agenda includes in-depth sessions on changes to the pricing and rebate system under the Inflation Reduction Act as well as proposed changes to the Medicaid Drug Rebate Program under the Centers for Medicare &amp; Medicaid Services’ (“CMS”) Proposed Rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.

Sessions will be held two days a week over the course of four weeks and examine:

Drug Pricing and Rebate Essentials and Introduction to Medicaid

core/list-item

PHS 340 B, VA and DoD Rx Pricing and Rebates

Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics

Pricing and Reimbursement for New Products and Therapies

core/list

A Guide to the Essentials of FSS Contracting for Pharmaceuticals with the VA and DOD Wednesday, November 13 1:00–2:15 p.m. EST

This session, part of the “PHS 340 B, VA and DoD Rx Pricing and Rebates, Part 2” program, will include:

Examining overall obligations when contracting with the federal government with respect to:

Understanding the significance of bifurcated tracks and when they are used

How is non-Federal Average Manufacturer Price (“non-FAMP”) calculated?

For more information and to register, please visit the&nbsp;<a href="https://www.americanconference.com/drug-pricing/">event webpage</a>.

A Guide to the Essentials of FSS Contracting for Pharmaceuticals with the VA and DOD

Offices

Stay Connected

Slide Menu

Slide Search

A Guide to the Essentials of FSS Contracting for Pharmaceuticals with the VA and DOD

Offices

Stay Connected